ORY-1001

ORY-1001

Catalog Number:
L002371310APE
Mfr. No.:
APE-B5882
Price:
$292
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          IC50: <20nM
          Lysine (K)-specific demethylase 1A (KDM1A, aka LSD1) is a key regulator of leukemia stem cell (LSC) potential and is required for MLL-AF9 oncogenic transformation. Inhibition of KDM1A expression or activity overcomes the differentiation block in AML. ORY-1001 is a selective inhibitor of KDM1A.
          In vitro: ORY-1001 is an enantiomerically pure KDM1A inhibitor with high selectivity against related FAD dependent aminoxidases. ORY-1001 does not inhibit non-related histone modifiers, and is clean in a CEREP diversity panel. Treatment of THP-1 cells with ORY-1001, results in a time/dose dependent me2H3K4 accumulation at KDM1A target genes and concomitant induction of differentiation markers [1].
          In vivo: Daily oral administration of doses < 0.020 mg/kg leads to significantly reduced tumor growth in rodent xenografts. In vivo studies have shown that ORY-1001 presents excellent oral bioavailability, target exposure and activity in vivo [1].
          Clinical trial: Oryzon Genomics announced the dosing of the first patient in the extension cohort (Part 2) of its ORY-1001 Phase I clinical trial. The trial will take place in 10 centers in Spain, UK and France.

      • Properties
        • Alternative Name
          N1-((1R,2S)-2-phenylcyclopropyl)cyclohexane-1,4-diamine
          CAS Number
          1431326-61-2
          Molecular Formula
          C15H24Cl2N2
          Molecular Weight
          303.27
          Appearance
          A solid
          Purity
          99.32%
          Solubility
          insoluble in EtOH; ≥23.15 mg/mL in H2O; ≥6.9 mg/mL in DMSO with gentle warming
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Hoang N, Zhang X, et al. "New histone demethylase LSD1 inhibitor selectively targets teratocarcinoma and embryonic carcinoma cells." Bioorg Med Chem. 2018 Feb 7. pii: S0968-0896(17)31942-9. PMID:29439916

    We Also Recommend

    EGF816

    $233

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.